The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer.
Utkan
G
G
Büyükçelik
A
A
Yalçyn
B
B
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D016896:Treatment Outcome
D004164:Diphosphonates; D000077557:Ibandronic Acid